生物科技真是深不可测,引以为戒啊,没能力买etf就好查看全文
chuminhua2020-11-22 11:09
11/16,美国食品和药物管理局(FDA)授予Rafael制药$Rafael Holdings(RFL)$ 公司的CPI-613,即devimistat,治疗胰腺癌的快速通道地位。Devimistat还获得了治疗骨髓增生异常综合征、急性髓系白血病、伯基特淋巴瘤、外周T细胞淋巴瘤和软组织肉瘤的孤儿药标签。$rafael查看全文
$Rafael Holdings(RFL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-042512 Size: 9 KB 网页链接
$Rafael Holdings(RFL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-035670 Size: 4 KB 网页链接
$Rafael Holdings(RFL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-035671 Size: 5 KB 网页链接
$Rafael Holdings(RFL)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001213900-24-022343 Act: 34 Size: 9 MB 网页链接
$Rafael Holdings(RFL)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001213900-24-022271 Act: 34 Size: 309 KB 网页链接
$Rafael Holdings(RFL)$ 8-K Current report, items 2.01 and 9.01 Accession Number: 0001213900-24-022185 Act: 34 Size: 204 KB 网页链接
$Rafael Holdings(RFL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-009772 Size: 11 KB 网页链接
$Rafael Holdings(RFL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-005202 Size: 5 KB 网页链接
$Rafael Holdings(RFL)$ 8-K Current report, item 5.07 Accession Number: 0001213900-24-003527 Act: 34 Size: 223 KB 网页链接
$Rafael Holdings(RFL)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000950170-24-004205 Size: 3 KB 网页链接